Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.39 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29503906 | 1.00 | MME (0.47) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL30193323 | 1.00 | MME (0.47) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL29591002 | 0.98 | MME (0.46) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL30782823 | 0.98 | MME (0.46) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL30881174 | 0.98 | MME (0.46) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL30886538 | 0.98 | MME (0.46) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL30099579 | 0.95 | MME (0.50) | MMEGNPATTGFBR1ENPEPPDCD1LG2 | |
| SCHEMBL29591607 | 0.95 | MME (0.50) | MMEGNPATTGFBR1ENPEPPDCD1LG2 | |
| SCHEMBL31064879 | 0.95 | GNPAT (0.48) | MMEGNPATTGFBR1CA2CA4 | |
| SCHEMBL29442612 | 0.95 | MME (0.47) | MMEGNPATTGFBR1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |